Use code MAJORITY54 at checkout for 15% off your first order, courtesy of Majority 54.
A New Probiotic for When You Drink
Using the power of genetic engineering, ZBiotics makes miserable mornings after drinking a thing of the past.
Free shipping on US orders. 100% Money-Back Guarantee.
A New Probiotic for When You Drink
A revolutionary pre-alcohol probiotic, made with the power of genetic engineering.
AS SEEN IN:
Meet ZBiotics®
You don't have to sacrifice a good night for a better morning.
THE PROBLEM
When you drink alcohol, an unwanted byproduct called acetaldehyde forms in your gut, creating particularly rough feelings for you the next morning.
THE SOLUTION
ZBiotics® Pre-Alcohol Probiotic Drink is the only product that breaks down acetaldehyde while you drink, helping you feel better the morning after.
With ZBiotics, I'm no longer playing Russian roulette with my productivity the next day. Life is too short to spend a whole day recovering.
Sophina T.
Scientist
ZBiotics has been such a huge help for me in reducing my anxiety around having a drink or two with friends during the week! What used to cause a very inevitable and very obvious drop in my productivity and creativity the next day is now an enjoyable, stress-free night with friends.
Kofi O.
Software engineer and singer/songwriter
One of the most practical and necessary synbio innovations yet - and yes, it actually works.
My husband and I don’t drink without it.
Abigail Y.
Startup Chief of Staff
How It Works
Real science, not just supplements.
Your liver is great at digesting acetaldehyde — the main culprit in those rough mornings after drinking. But unfortunately, most acetaldehyde accumulates in your gut, creating problems the next day.
So we used biotechnology to build a solution: a genetically engineered probiotic that produces the same type of enzyme as your liver. Simply put, it replicates your liver’s natural process where it matters most: your gut.
Meet our Lead Scientists
Dr. Zack Abbott, CEO
PhD, MICROBIOLOGY & IMMUNOLOGY
University of Michigan
Dr. John W.K. Oliver, VP of R&D
PhD, CHEMISTRY
University of California, Davis
Wyss Institute, Harvard Medical School